We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.9B
AUM Growth
-$428M
Cap. Flow
-$938M
Cap. Flow %
-6.29%
Top 10 Hldgs %
21.36%
Holding
1,841
New
125
Increased
760
Reduced
901
Closed
50

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$84.7M
2
AMZN icon
Amazon
AMZN
+$51.3M
3
MSFT icon
Microsoft
MSFT
+$51.2M
4
META icon
Meta Platforms (Facebook)
META
+$26.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.6M

Sector Composition

Rank Sector Weight
1 Technology 19.18%
2 Financials 13.19%
3 Healthcare 12.85%
4 Consumer Discretionary 10.78%
5 Communication Services 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDR
1051
DELISTED
Alder Biopharmaceuticals
ALDR
$572K ﹤0.01%
36,187
-3,283
-8% -$49.9K
PTEN icon
1052
Patterson-UTI
PTEN
$3.87B
$567K ﹤0.01%
31,479
-2,136
-6% -$42.8K
GPOR
1053
DELISTED
Gulfport Energy Corp.
GPOR
$567K ﹤0.01%
45,096
+20,285
+82% +$209K
KBR icon
1054
KBR
KBR
$4.68B
$566K ﹤0.01%
31,595
+737
+2% +$12.8K
GNTX icon
1055
Gentex
GNTX
$4.88B
$563K ﹤0.01%
24,471
-76
-0.3% -$1.8K
AHL
1056
DELISTED
ASPEN Insurance Holding Limited
AHL
$563K ﹤0.01%
13,831
+49
+0.4% +$2.11K
PAY
1057
DELISTED
Verifone Systems Inc
PAY
$562K ﹤0.01%
24,626
+513
+2% +$11.4K
ESPR
1058
DELISTED
Esperion Therapeutics
ESPR
$559K ﹤0.01%
14,271
-192
-1% -$9.7K
CHE icon
1059
Chemed
CHE
$6.78B
$558K ﹤0.01%
1,733
-1,198
-41% -$375K
DK icon
1060
Delek US
DK
$3.87B
$556K ﹤0.01%
11,090
+780
+8% +$38.8K
AXON
1061
Axon Enterprise
AXON
$40.5B
$555K ﹤0.01%
8,780
+470
+6% +$25.4K
CARS icon
1062
Cars.com
CARS
$641M
$555K ﹤0.01%
19,532
+879
+5% +$24.2K
BDC icon
1063
Belden
BDC
$4B
$554K ﹤0.01%
9,069
-143
-2% -$8.76K
SAM icon
1064
Boston Beer
SAM
$1.88B
$554K ﹤0.01%
1,850
+41
+2% +$9.99K
TTEK icon
1065
Tetra Tech
TTEK
$8.23B
$553K ﹤0.01%
47,300
+1,070
+2% +$11.4K
JACK icon
1066
Jack in the Box
JACK
$278M
$551K ﹤0.01%
6,476
+68
+1% +$5.87K
DAR icon
1067
Darling Ingredients
DAR
$9.93B
$550K ﹤0.01%
27,685
+670
+2% +$12.1K
JBLU icon
1068
JetBlue
JBLU
$1.96B
$549K ﹤0.01%
28,950
+58
+0.2% +$1.12K
SSNC icon
1069
SS&C Technologies
SSNC
$17.8B
$549K ﹤0.01%
10,570
+2,484
+31% +$126K
VNDA icon
1070
Vanda Pharmaceuticals
VNDA
$312M
$546K ﹤0.01%
28,661
+2,023
+8% +$33.8K
POOL icon
1071
Pool Corp
POOL
$6.7B
$545K ﹤0.01%
3,600
+2
+0.1% +$294
RVNC
1072
DELISTED
Revance Therapeutics, Inc.
RVNC
$543K ﹤0.01%
19,781
-526
-3% -$15.8K
VIAV icon
1073
Viavi Solutions
VIAV
$9.75B
$542K ﹤0.01%
52,891
+3,445
+7% +$34.1K
WWW icon
1074
Wolverine World Wide
WWW
$1.54B
$542K ﹤0.01%
15,590
+247
+2% +$8K
VMW
1075
DELISTED
VMware, Inc
VMW
$541K ﹤0.01%
3,681
+488
+15% +$67.3K

Similar funds

ProShare Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, ProShare Advisors held 1,841 positions worth $14.9B, down 2.8% from $15.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors withdrew a net $938M in Q2 2018, closing 50 positions and reducing 901 holdings. Its most notable exit was Monsanto Co, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ProShare Advisors opened a new position in First of Long Island Corp worth $6.18M.

  • ProShare Advisors's largest Q2 2018 buy was First of Long Island Corp: 248,853 shares worth $6.18M.
  • ProShare Advisors added most to Walgreens Boots Alliance in Q2 2018, an estimated $15M increase.
  • ProShare Advisors's biggest Q2 2018 reduction was Apple, cutting an estimated $84.7M.
  • ProShare Advisors fully exited Monsanto Co in Q2 2018, selling an estimated $11.2M.
  • ProShare Advisors's ten largest holdings make up 21% of its $14.9B portfolio in Q2 2018.
  • ProShare Advisors opened 125 new positions and closed 50 in Q2 2018.
  • ProShare Advisors's portfolio value fell 2.8% quarter-over-quarter to $14.9B.

Based on ProShare Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.